نتائج البحث - "Julia M. Greene"

1

دورية أكاديمية

Final analysis of a phase I/IIa trial of the folate‐binding protein‐derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients

المؤلفون: Tommy A. Brown, Kevin Byrd, Timothy J. Vreeland, Guy T. Clifton, Doreen O. Jackson, Diane F. Hale, Garth S. Herbert, John W. Myers, Julia M. Greene, John S. Berry, Jonathan Martin, John C. Elkas, Thomas P. Conrads, Kathleen M. Darcy, Chad A. Hamilton, George L. Maxwel, George E. Peoples

المصدر: Cancer Medicine, Vol 8, Iss 10, Pp 4678-4687 (2019)

مصطلحات موضوعية: E39, endometrial cancer, FBP, immunotherapy, ovarian cancer, vaccine, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2045-7634

URL الوصول: https://doaj.org/article/f15fd5bad15e44cabf5f4b8e235a3c91

View record at Wiley

Find this article in full text from ProQuest

Full Text Finder

2

Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence

المصدر: Breast Cancer Research and Treatment

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Receptor, ErbB-2, medicine.medical_treatment, Disease, law.invention, 0302 clinical medicine, Breast cancer, Randomized controlled trial, law, Single-Blind Method, Prospective Studies, skin and connective tissue diseases, Carcinoma, Ductal, Breast, Middle Aged, Prognosis, Clinical Trial, Gene Expression Regulation, Neoplastic, Survival Rate, Receptors, Estrogen, 030220 oncology & carcinogenesis, Vaccines, Subunit, Female, Immunotherapy, Receptors, Progesterone, Adult, medicine.medical_specialty, Subgroup analysis, Breast Neoplasms, 03 medical and health sciences, Internal medicine, HER2, medicine, Biomarkers, Tumor, Humans, In patient, Neoplasm Invasiveness, AE37, business.industry, GP2, Significant difference, medicine.disease, Peptide Fragments, Carcinoma, Lobular, 030104 developmental biology, Landmark analysis, Neoplasm Recurrence, Local, business, Vaccine, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a5ae2ea6470bd9f8fda4a1afe801b91
http://europepmc.org/articles/PMC7188712

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

3

Final analysis of a phase I/IIa trial of the folate‐binding protein‐derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients

المؤلفون: Timothy J. Vreeland, Chad A. Hamilton, John S. Berry, Kathleen M. Darcy, George E. Peoples, Garth S. Herbert, Kevin Byrd, Jonathan W. Martin, Tommy A. Brown, Julia M. Greene, Diane F. Hale, George L. Maxwel, Guy T. Clifton, John W. Myers, Doreen O. Jackson, John C. Elkas, Thomas P. Conrads

المصدر: Cancer Medicine, Vol 8, Iss 10, Pp 4678-4687 (2019)
Cancer Medicine

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.medical_treatment, Primary disease, Gastroenterology, FBP, 0302 clinical medicine, vaccine, Prospective Studies, Original Research, Ovarian Neoplasms, Folate Receptors, GPI-Anchored, Middle Aged, Immunogenic peptide, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Treatment Outcome, ovarian cancer, Oncology, 030220 oncology & carcinogenesis, Vaccines, Subunit, endometrial cancer, Female, immunotherapy, medicine.medical_specialty, Immunization, Secondary, Cancer Vaccines, lcsh:RC254-282, 03 medical and health sciences, Internal medicine, HLA-A2 Antigen, medicine, Humans, Radiology, Nuclear Medicine and imaging, Aged, Dose-Response Relationship, Drug, business.industry, Endometrial cancer, E39, Granulocyte-Macrophage Colony-Stimulating Factor, Clinical Cancer Research, Immunotherapy, medicine.disease, Survival Analysis, Folate-binding protein, Endometrial Neoplasms, 030104 developmental biology, Landmark analysis, Peptide vaccine, Neoplasm Recurrence, Local, business, Ovarian cancer

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa939a69a79276515650a729462bcfe0
https://doaj.org/article/f15fd5bad15e44cabf5f4b8e235a3c91

View record at Wiley

Find this article in full text from ProQuest

4

Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumors

المؤلفون: Thomas E. Wagner, George E. Peoples, Guy T. Clifton, Xianzhong Yu, Pauline Nichol, Mark O. Hardin, Diane F. Hale, Doreen O. Jackson, John S. Berry, Julia M. Greene, Garth S. Herbert, Timothy J. Vreeland, Sook Yin

المصدر: Vaccine. 36:3247-3253

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3753b8d45d3f7e3fb9f0584e1750b74
https://doi.org/10.1016/j.vaccine.2018.04.078

View record from ScienceDirect

Find this article in full text from ProQuest

Full Text via ClinicalKey

5

Tumor lysate particle loaded dendritic cell vaccine: preclinical testing of a novel personalized cancer vaccine

المؤلفون: Timothy J. Vreeland, Guy T. Clifton, Doreen O. Jackson, George E. Peoples, Pauline Nichols, Garth S. Herbert, John E Berry, Diane F. Hale, Mark O. Hardin, Julia M. Greene, Sook Yin, Xianzhong Yu, Thomas E. Wagner

المصدر: Immunotherapy. 10:373-382

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2475524195f10c7af917b5a4fd08a22e
https://doi.org/10.2217/imt-2017-0114

PDF full text from Publisher

Find this article in full text from ProQuest

6

Abstract P6-10-04: Determining the optimal vaccination strategy using a combination of the folate binding protein (FBP) peptide vaccine (E39+GM-CSF) and an attenuated version (E39') to maximize the immunologic response in breast cancer patients

المؤلفون: Timothy J. Vreeland, A Toms, Julia M. Greene, Nuhad K. Ibrahim, Na Qiao, Doreen O. Jackson, EA Mittendorf, Guy T. Clifton, Kaitlin M. Peace, Diane F. Hale, George E. Peoples, Alfred F. Trappey, John S. Berry

المصدر: Cancer Research. 77:P6-10

مصطلحات موضوعية: Vaccination, Cancer Research, Breast cancer, Oncology, business.industry, Immunology, Peptide vaccine, Medicine, business, medicine.disease, Folate-binding protein

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::469a38661dde8e2171384098e57826d3
https://doi.org/10.1158/1538-7445.sabcs16-p6-10-04

7

Evaluation of Attenuated Tumor Antigens and the Implications for Peptide-Based Cancer Vaccine Development

المؤلفون: George E. Peoples, Alfred F. Trappey, Guy T. Clifton, Julia M. Greene, D F Hale, Timothy J. Vreeland, Garth S. Herbert, John S. Berry, Doreen O. Jackson, Mark O. Hardin

المصدر: Journal of Cancer

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::368e777627e6829f67b8e4d54a814c91
https://doi.org/10.7150/jca.16450

8

A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor–dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2

المؤلفون: Madeline Flores, Garth S. Herbert, Jonathan Martin, Diane F. Hale, Xianzhong Yu, George E. Peoples, Mark O. Hardin, Julia M. Greene, Doreen O. Jackson, Timothy J. Vreeland, Erika J Schneble, Thomas E. Wagner

المصدر: Cancer Immunology, Immunotherapy. 65:383-392

مصطلحات موضوعية: Male, 0301 basic medicine, Interleukin 2, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Immunology, Kaplan-Meier Estimate, Cancer Vaccines, Gastroenterology, Drug Administration Schedule, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Immunology and Allergy, Stage (cooking), Melanoma, Aged, Neoplasm Staging, Dose-Response Relationship, Drug, business.industry, Nausea, Dendritic Cells, Immunotherapy, Middle Aged, medicine.disease, Arthralgia, Combined Modality Therapy, Chills, Surgery, Clinical trial, Treatment Outcome, 030104 developmental biology, Cytokine, Oncology, Erythema, 030220 oncology & carcinogenesis, Toxicity, Interleukin-2, Female, Neoplasm Recurrence, Local, business, Adjuvant, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85d694175b63c7df2e484becc19ecc28
https://doi.org/10.1007/s00262-016-1809-6

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

9

Abstract P2-11-01: Final pre-specified analysis of the phase II trial of the GP2+GM-CSF peptide vaccine in high risk breast cancer patients to prevent recurrence

المؤلفون: Timothy J. Vreeland, Julia M. Greene, Jennifer K. Litton, Michael Papamichail, Sonia A. Perez, Alexandros Ardavanis, Guy T. Clifton, Nathan M. Shumway, James L. Murray, Erika J Schneble, Diane F. Hale, George E. Peoples, EA Mittendorf, John S. Berry, Alfred F. Trappey

المصدر: Cancer Research. 76:P2-11

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Breast cancer, business.industry, Internal medicine, Immunology, Peptide vaccine, medicine, medicine.disease, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::cf0ace20ceacf0ee40453d9345fb86c3
https://doi.org/10.1158/1538-7445.sabcs15-p2-11-01

10

Phase Ib Trial of Folate Binding Protein (FBP)-Derived Peptide Vaccines, E39 and an Attenuated Version, E39′: An Analysis of Safety and immune Response

المؤلفون: George E. Peoples, Julia M. Greene, Jennifer K. Litton, Na Qiao, Elizabeth A. Mittendorf, Kaitlin M. Peace, Guy T. Clifton, Timothy J. Vreeland, John S. Berry, Gheath Alatrash, Diane F. Hale, Anne V. Philips, Doreen O. Jackson

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0df5c2928021e21a4c44f640f5908100
https://europepmc.org/articles/PMC5988975/

تنقيح النتائج